Özkan Ufuk Nalbantoğlu (O Ufuk Nalbantoglu, Ozkan Ufuk Nalbantoglu)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Topics

Randomized Controlled Trial

Irritable Bowel Syndrome

Artificial Intelligence

Palliative Care

Top Venues

The American journal of gastroenterology

Journal of clinical medicine

Entropy (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Varol Tunali, Naciye Çiğdem Arslan, Beyza Hilal Ermiş, Gözde Derviş Hakim, Aycan Gündoğdu, Mehmet Hora, Özkan Ufuk Nalbantoğlu
A Multicenter Randomized Controlled Trial of Microbiome-Based Artificial Intelligence-Assisted Personalized Diet vs Low-Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Diet: A Novel Approach for the Management of Irritable Bowel Syndrome. The American journal of gastroenterology (2024)
Varol Tunali, Naciye Çiğdem Arslan, Beyza Hilal Ermiş, Gözde Derviş Hakim, Aycan Gündoğdu, Mehmet Hora, Özkan Ufuk Nalbantoğlu
A Multicenter Randomized Controlled Trial of Microbiome-Based Artificial Intelligence-Assisted Personalized Diet vs Low-Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Diet: A Novel Approach for the Management of Irritable Bowel Syndrome. The American journal of gastroenterology (2024)
Varol Tunali, Naciye Çiğdem Arslan, Beyza Hilal Ermiş, Gözde Derviş Hakim, Aycan Gündoğdu, Mehmet Hora, Özkan Ufuk Nalbantoğlu
A Multicenter Randomized Controlled Trial of Microbiome-Based Artificial Intelligence-Assisted Personalized Diet vs Low-Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Diet: A Novel Approach for the Management of Irritable Bowel Syndrome. The American journal of gastroenterology (2024)
Varol Tunali, Naciye Çiğdem Arslan, Beyza Hilal Ermiş, Gözde Derviş Hakim, Aycan Gündoğdu, Mehmet Hora, Özkan Ufuk Nalbantoğlu
A Multicenter Randomized Controlled Trial of Microbiome-Based Artificial Intelligence-Assisted Personalized Diet vs Low-Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Diet: A Novel Approach for the Management of Irritable Bowel Syndrome. The American journal of gastroenterology (2024)
Varol Tunali, Naciye Çiğdem Arslan, Beyza Hilal Ermiş, Gözde Derviş Hakim, Aycan Gündoğdu, Mehmet Hora, Özkan Ufuk Nalbantoğlu
A Multicenter Randomized Controlled Trial Of Microbiome-Based Artifıcial Intelligence-Assisted Personalized Diet Vs Low Fodmap Diet: A Novel Approach for the Management of Irritable Bowel Syndrome. The American journal of gastroenterology (2024)
Naciye Çiğdem Arslan, Aycan Gündoğdu, Varol Tunali, Oğuzhan Hakan Topgül, Damla Beyazgül, Özkan Ufuk Nalbantoğlu
Efficacy of AI-Assisted Personalized Microbiome Modulation by Diet in Functional Constipation: A Randomized Controlled Trial. Journal of clinical medicine 11 (22) (2022)
Tarkan Karakan, Aycan Gundogdu, Hakan Alagözlü, Nergiz Ekmen, Seckin Ozgul, Varol Tunali, Mehmet Hora, Damla Beyazgul, Özkan Ufuk Nalbantoğlu
Artificial intelligence-based personalized diet: A pilot clinical study for irritable bowel syndrome. Gut microbes 14 (1) (2022)
Özkan Ufuk Nalbantoğlu
Information Theoretic Metagenome Assembly Allows the Discovery of Disease Biomarkers in Human Microbiome. Entropy (Basel, Switzerland) 23 (2) (2021)
Özkan Ufuk Nalbantoğlu
Group testing performance evaluation for SARS-CoV-2 massive scale screening and testing. BMC medical research methodology 20 (1) (2020)